Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-00-013650
Filing Date
2000-03-27
Accepted
2000-03-27 00:00:00
Documents
5
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 10-K 10-K 216433
2 EXHIBIT 10.29 EX-10.29 7742
3 EXHIBIT 10.30 EX-10.30 4395
4 EXHIBIT 23.1 EX-23.1 838
5 EXHIBIT 27.1 EX-27.1 2363
  Complete submission text file 0000912057-00-013650.txt   233591
Mailing Address 3031 RESEARCH DRIVE 3031 RESEARCH DRIVE RICHMOND CA 94806
Business Address 3031 RESEARCH DR BLDG A RICHMOND CA 94806 5102229700
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28298 | Film No.: 579132
SIC: 2836 Biological Products, (No Diagnostic Substances)